Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QSIT Validation Study Shows Promise Of New Inspection Technique - FDA

This article was originally published in The Gray Sheet

Executive Summary

Preliminary results from an FDA study to validate the agency's Quality System Inspection Technique (QSIT) program indicate that QSIT inspections are averaging 43 hours total time. That figure compares to an average of 65-80 total hours for regular inspections, FDA officials say.

You may also be interested in...



Reduce Warning Letter Threshold In Draft CPG, HIMA Advises FDA

FDA inspectors should not consider the failure of a manufacturer to meet a single inspectional objective or part of an inspectional objective as a major deficiency worthy of a warning letter, the Health Industry Manufacturers Association recommends in comments on FDA's draft compliance program guidance.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel